Benzinga | Sep 20, 2021 08:23AM EDT

Stifel Initiates Coverage On eFFECTOR Therapeutics with Hold Rating, Announces Price Target of $20

Stifel analyst Benjamin Burnett initiates coverage on eFFECTOR Therapeutics (NASDAQ:EFTR) with a Hold rating and announces Price Target of $20.